Table 1.

Patient characteristics and risk factors for development of central nervous system complications within 6 months after hematopoietic stem cell transplant.

^a)Other BMF included pure red cell anemia and Kostmann syndrome, ^b)Immunodeficiency included chronic granulomatous disease, severe combined immunodeficiency, Omenn syndrome, and Wiskott-Aldrich syndrome, ^c)Storage disease included Krabbe disease and adrenoleukodystrophy.

Abbreviations: CNS, central nervous system; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; BAL, biphenotypic acute leukemia; CML, chronic myelogenous leukemia; JMML, juvenile myelomonocytic leukemia; MDS, myelodysplastic syndrome; HLH, hemophagocytic lymphohistiocytosis; SAA, severe aplastic anemia; BMF, bone marrow failure; TBI, total body irradiation; ATG, antithymocyte globulin; MTX, methotrexate; MMF, mycophenolate mofetil; GVHD, graft-versus-host disease; NA, not applicable.